Full-Time
Updated on 5/11/2026
Empathetic research and support for autism
$95k - $110k/yr
California, USA
Hybrid
Hybrid model: telehealth plus in-person visits; Monterey County area travel required.
Kyo works to improve life outcomes for people with autism by combining scientific inquiry with empathy in all its efforts. It partners with driven, open and ambitious individuals to tackle large challenges and create programs and initiatives that benefit the autism community and those who work with them. Its offerings are collaborative and people-centered, designed to produce practical, real-world impact rather than just theory, using a mix of research-informed approaches and compassionate practice. The company differentiates itself by weaving empathy into scientific discovery and by focusing on community-driven impact—helping teams do meaningful work together, both in person and remotely. The ultimate goal is to change what is possible for people with autism and to create a more fulfilling life for clients, their teams, and the communities around them.
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Daly City, California
Founded
2005
Help us improve and share your feedback! Did you find this helpful?
Flexible Work Hours
Paid Vacation
Paid Sick Leave
Employee Assistance Program (EAP)
401(k) Company Match
Phone/Internet Stipend
"In partnership with Magellan, Kyo launched ABA Optimized a year ago as our flagship treatment model for people with autism," said Colin Davitian, CEO of Kyo.
In December 2022, Magellan Health announced it teamed up with Daly City, California-based Kyo Autism Therapy to develop outcome standards for autism therapies.
FRISCO, Texas--(BUSINESS WIRE)--Magellan Healthcare, Inc., the behavioral health division of Magellan Health, Inc., announced today the launch of a first-to-market, value-based collaboration with Kyo Autism Therapy, LLC, a California-based Applied Behavior Analysis (ABA) provider, to drive meaningful and objectively measurable outcomes for children with autism spectrum disorder (ASD). Magellan and Kyo will develop, build and test a value-based model for treatment planning and delivery to continuously improve care for children with ASD and help the families who care for them. Findings will be used to establish evidence-based practices and drive outcomes-based programs across the ABA industry